Literature DB >> 15475138

The time-related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients.

Ulku Altoparlak1, Serpil Erol, Mufide N Akcay, Fehmi Celebi, Ayten Kadanali.   

Abstract

To examine the bacterial isolates from the burn patients and to compare the antibiograms of the predominant bacteria isolated from 51 patients who were hospitalized at least 3 weeks or more over a period of 7 months, a prospective study was undertaken. Periodic swabs were taken from burn wound, nasal, axillary, inguinal, and umbilical region of the patients on admission and on 7th, 14th, and 21st days of hospitalization. Mean hospital stay was 36.5 days. A total of 1098 microbial isolates were detected during the study period. Coagulase-negative staphylococci (CNS, 63.0%) and Staphylococcus aureus (19.7%) were the most prevalent isolates in admission cultures. During the next weeks, these bacteria were superceded by mainly Pseudomonas aeruginosa. Between admission and 21st day, the rates of methicillin resistance of staphylococci strains increased steadily. There was no vancomycin resistance in any staphylococci strains, although nine of the S. aureus isolates (2.7%) were resistant to teicoplanin. There were no strains producing inducible beta lactamase (IBL) among P. aeruginosa strains. One extended-spectrum beta-lactamase (ESBL)-producing strain was recovered on admission, although strains producing IBL and ESBL were detected at rates of 79.6 and 57.1%, respectively, on the 21st day. The nature of microbial wound colonization, flora changes, and antimicrobial sensitivity profiles should be taken into consideration in using empirical antimicrobial therapy of burned patients.

Entities:  

Mesh:

Year:  2004        PMID: 15475138     DOI: 10.1016/j.burns.2004.03.005

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  50 in total

Review 1.  Microbiota restoration: natural and supplemented recovery of human microbial communities.

Authors:  Gregor Reid; Jessica A Younes; Henny C Van der Mei; Gregory B Gloor; Rob Knight; Henk J Busscher
Journal:  Nat Rev Microbiol       Date:  2010-11-29       Impact factor: 60.633

Review 2.  Paraoxonases as protective agents against N-acyl homoserine lactone - producing pathogenic microorganisms.

Authors:  Bogdan Nicolae Manolescu
Journal:  Maedica (Bucur)       Date:  2013-03

3.  Prevalence of beta lactamase producing species of pseudomonas and acinetobacter in pediatric burn patients.

Authors:  B Sobouti; N Khosravi; A Daneshvar; S Fallah; M Moradi; Y Ghavami
Journal:  Ann Burns Fire Disasters       Date:  2015-09-30

4.  Experimental phage therapy of burn wound infection: difficult first steps.

Authors:  Thomas Rose; Gilbert Verbeken; Daniel De Vos; Maya Merabishvili; Mario Vaneechoutte; Rob Lavigne; Serge Jennes; Martin Zizi; Jean-Paul Pirnay
Journal:  Int J Burns Trauma       Date:  2014-10-26

Review 5.  Management and prevention of drug resistant infections in burn patients.

Authors:  Roohi Vinaik; Dalia Barayan; Shahriar Shahrokhi; Marc G Jeschke
Journal:  Expert Rev Anti Infect Ther       Date:  2019-08-04       Impact factor: 5.091

6.  Role of Daptomycin on Burn Wound Healing in an Animal Methicillin-Resistant Staphylococcus aureus Infection Model.

Authors:  Oriana Simonetti; Guendalina Lucarini; Fiorenza Orlando; Elisa Pierpaoli; Roberto Ghiselli; Mauro Provinciali; Pamela Castelli; Mario Guerrieri; Roberto Di Primio; Annamaria Offidani; Andrea Giacometti; Oscar Cirioni
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

7.  Study on biofilm formation in burn wound infection in a pediatric hospital in Chennai, India.

Authors:  M Ramakrishnan; S Putli Bai; M Babu
Journal:  Ann Burns Fire Disasters       Date:  2016-12-31

8.  Cerium nitrate enhances anti-bacterial effects and imparts anti-inflammatory properties to silver dressings in a rat scald burn model.

Authors:  Li-Wu Qian; Andrea B Fourcaudot; Ping Chen; Kenneth S Brandenburg; Alan J Weaver; Kai P Leung
Journal:  Int J Burns Trauma       Date:  2020-08-15

Review 9.  Nanofibers offer alternative ways to the treatment of skin infections.

Authors:  T D J Heunis; L M T Dicks
Journal:  J Biomed Biotechnol       Date:  2010-07-28

10.  Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials.

Authors:  Maya Merabishvili; Jean-Paul Pirnay; Gilbert Verbeken; Nina Chanishvili; Marina Tediashvili; Nino Lashkhi; Thea Glonti; Victor Krylov; Jan Mast; Luc Van Parys; Rob Lavigne; Guido Volckaert; Wesley Mattheus; Gunther Verween; Peter De Corte; Thomas Rose; Serge Jennes; Martin Zizi; Daniel De Vos; Mario Vaneechoutte
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.